Welspun Specialty Solution Intrinsic Value
WELSPLSOL • Industrial Products
Current Stock Price
₹31.24
Primary Intrinsic Value
₹9.37
Market Cap
₹1243 Cr
-65.1%
Downside
Median Value
₹10.90
Value Range
₹9 - ₹18
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%
WELSPLSOL Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹9.37 | ₹7.50 - ₹11.24 | -70.0% | EPS: ₹0.30, Sector P/E: 12x |
| Book Value Method | asset | ₹10.90 | ₹9.81 - ₹11.99 | -65.1% | Book Value/Share: ₹10.90, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹17.91 | ₹16.12 - ₹19.70 | -42.7% | Revenue/Share: ₹22.39, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹12.50 | ₹11.25 - ₹13.75 | -60.0% | EBITDA: ₹70.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹16.71 | ₹13.37 - ₹20.05 | -46.5% | CF Growth: 10.5%, Discount: 15% |
| PEG Ratio Method | growth | ₹9.37 | ₹8.43 - ₹10.31 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹9.37 | ₹8.43 - ₹10.31 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹15.62 | ₹14.06 - ₹17.18 | -50.0% | ROE: 5.1%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹9.37 | ₹8.43 - ₹10.31 | -70.0% | EPS: ₹0.30, BVPS: ₹10.90 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
WELSPLSOL Intrinsic Value Analysis
What is the intrinsic value of WELSPLSOL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Welspun Specialty Solution (WELSPLSOL) is ₹10.90 (median value). With the current market price of ₹31.24, this represents a -65.1% variance from our estimated fair value.
The valuation range spans from ₹9.37 to ₹17.91, indicating ₹9.37 - ₹17.91.
Is WELSPLSOL undervalued or overvalued?
Based on our multi-method analysis, Welspun Specialty Solution (WELSPLSOL) appears to be trading above calculated value by approximately 65.1%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 20.38 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 5.1% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.22x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Welspun Specialty Solution
Additional stock information and data for WELSPLSOL
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹58 Cr | ₹39 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹8 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹50 Cr | ₹48 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-84 Cr | ₹-87 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹43 Cr | ₹39 Cr | Positive Free Cash Flow | 8/10 |